Evaluation of glucagon secretion during 75g-OGTT to predict requirement of insulin therapy, perinatal outcome, and development of type 2 diabetes after delivery in Japanese patients with gestational diabetes.
Not Applicable
Completed
- Conditions
- Gestational diabetes
- Registration Number
- JPRN-UMIN000034337
- Lead Sponsor
- agasaki University
- Brief Summary
Impaired early-phase suppression of glucagon could be associated with the requirement for insulin treatment during pregnancy in patients with GDM.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 49
Inclusion Criteria
Not provided
Exclusion Criteria
Type 1 diabetes. Type 2 diabetes. GDM who had been treated with insulin before enrollment of the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin requirement during pregnancy
- Secondary Outcome Measures
Name Time Method Perinatal mortality. Development of type 2 diabetes after delivery.